Increasing levels of pretreatment HIV drug resistance and safety concerns for dolutegravir use in women of reproductive age. (2019)
Attributed to:
Pathogen Genomics, Phenotype and Immunity (PGPI) & Basic Sciences Programme
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/qad.0000000000002277
PubMed Identifier: 31149946
Publication URI: http://europepmc.org/abstract/MED/31149946
Type: Journal Article/Review
Volume: 33
Parent Publication: AIDS (London, England)
Issue: 11
ISSN: 0269-9370